Pacemakers have saved a lot of lives over the years by helping to regulate the heartbeats of those with arrhythmia. The problem, however, is that those pacemakers run on batteries that have a tendency to run out of juice after a while. As a result, patients have to undergo an invasive procedure every once in a while in order to stay alive. By utilizing the technology that allows wristwatches to function, this problem may have finally been addressed.
The researchers responsible for the discovery are Andreas Haeberlin and Adrian Zurbuchen from the University of Bern and the University of Michigan, Futurism reports. The method that the pair proposed basically involves initiating a cycle between the pacemaker and the heart, where the heartbeat will give the pacemaker power via kinetic energy and the pacemaker will give the heart assistance in order to maintain a consistent rhythm.
By setting the system up like this, it creates a loop where the pacemaker is continuously powered and the heartbeat is continuously maintained to have a normal pace. Basically, the researchers just made the heart the battery for the thing that’s keeping it working. A symbiotic relationship, in a sense.
Aside from pacemakers, this discovery could potentially also have an impact on other implanted devices, TechXplore reports. These could include defibrillators or electrical stimulators that keep important organs from ceasing to function. This is a solution that addresses one of the biggest problems involved in implanted devices.
"Repeated battery replacement procedures can be avoided by extending the implants lifespan, which is the goal of energy harvesting concepts,” the Abstract of the paper reads. This reduces the risk of complications for the patient and may even reduce device size. The continuous and powerful contractions of a human heart ideally qualify as a battery substitute."


Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
SpaceX Reportedly Preparing Record-Breaking IPO Targeting $1.5 Trillion Valuation
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
China Adds Domestic AI Chips to Government Procurement List as U.S. Considers Easing Nvidia Export Curbs
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
Trump Signs Executive Order to Establish National AI Regulation Standard
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
Australia Enforces World-First Social Media Age Limit as Global Regulation Looms
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 



